Daxor reports 45% revenue growth, plans regulatory shift to Exchange Act Mar 3, 2026 08:32AM
Daxor reports 45% revenue growth, plans regulatory shift to Exchange Act Mar 3, 2026 08:32AM
Daxor launches blood volume diagnostic program in Tennessee Feb 24, 2026 08:06AM
Lake Street Capital Markets Starts Daxor Corp. (DXR) at Buy Feb 11, 2026 08:22AM
Daxor transitions to Exchange Act reporting framework Feb 10, 2026 08:04AM


Sep 23, 2025 08:04AM Daxor Corporation Unveils Next-Gen BVA Analyzer
Aug 7, 2025 07:58AM Daxor receives FDA clearance for rapid blood volume analyzer
Apr 10, 2025 08:02AM Daxor Corp. (DXR) Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
Apr 2, 2025 08:02AM Daxor Corp. (DXR) Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
Mar 4, 2025 08:06AM Daxor Corp. (DXR) CEO Provides Corporate Update in Letter to Shareholders
Feb 19, 2025 08:03AM Daxor Corp. (DXR) Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
Sep 5, 2024 08:01AM Daxor Corp. (DXR) Receives $300K Matching Fund Award From Launch Tennessee
Sep 3, 2024 04:06PM Daxor Corp. (DXR) CEO Feldschuh Delivers Corporate Update in Shareholder Letter